Compare NUVB & EXK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NUVB | EXK |
|---|---|---|
| Founded | 2018 | 1981 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.4B |
| IPO Year | N/A | N/A |
| Metric | NUVB | EXK |
|---|---|---|
| Price | $6.01 | $12.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 4 |
| Target Price | $10.44 | ★ $13.31 |
| AVG Volume (30 Days) | 6.3M | ★ 14.9M |
| Earning Date | 03-05-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $26,748,000.00 | ★ $337,137,000.00 |
| Revenue This Year | $616.63 | $111.57 |
| Revenue Next Year | $202.59 | $64.09 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1137.19 | 49.22 |
| 52 Week Low | $1.54 | $2.95 |
| 52 Week High | $9.75 | $11.72 |
| Indicator | NUVB | EXK |
|---|---|---|
| Relative Strength Index (RSI) | 29.46 | 72.07 |
| Support Level | $6.07 | $10.57 |
| Resistance Level | $6.63 | $10.60 |
| Average True Range (ATR) | 0.53 | 0.79 |
| MACD | -0.39 | 0.17 |
| Stochastic Oscillator | 11.03 | 93.10 |
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.
Endeavour Silver Corp is a Canadian mineral company engaged in the evaluation, acquisition, exploration, development, and exploitation of precious metal properties in Mexico and Chile. The Company has two operating mining segments which are located in Mexico, Guanacevi and Bolanitos. The company has one development project in Mexico, Terronera, as well as Exploration and Corporate segments. The Exploration segment consists of projects in the exploration and evaluation phases in Mexico, Chile, and the USA.